BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37351152)

  • 21. Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction.
    Wyatt CR; Wingett D; White JS; Buck CD; Knowles D; Reeves R; Magnuson NS
    J Virol; 1989 Nov; 63(11):4498-506. PubMed ID: 2552135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulative effects of bovine immunodeficiency-like virus (BIV)-infection and mixed infection of BIV and bovine leukemia virus on sheep.
    Hirai N; Kabeya H; Ohashi K; Sugimoto C; Onuma M
    Jpn J Vet Res; 1996 Dec; 44(3):153-63. PubMed ID: 8997876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
    Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
    Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell lymphotropic virus tax and Epstein-Barr virus DNA in peripheral blood of multiple sclerosis patients during acute attack.
    Ferrante P; Omodeo-Zorini E; Zuffolato MR; Mancuso R; Caldarelli-Stefano R; Puricelli S; Mediati M; Losciale L; Caputo D
    Acta Neurol Scand Suppl; 1997; 169():79-85. PubMed ID: 9174643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive.
    Alvarez-Lafuente R; de las Heras V; García-Montojo M; Bartolomé M; Arroyo R
    Mult Scler; 2007 Jun; 13(5):578-83. PubMed ID: 17548435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bovine immunodeficiency virus and bovine leukemia virus and their mixed infection in Iranian Holstein cattle.
    Brujeni GN; Poorbazargani TT; Nadin-Davis S; Tolooie M; Barjesteh N
    J Infect Dev Ctries; 2010 Oct; 4(9):576-9. PubMed ID: 21045371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose.
    Abolghasemi M; Ali Ashrafi S; Asadi M; Shanehbandi D; Sadigh Etehad S; Poursaei E; Nejadghaderi SA; Shaafi S
    Mol Biol Rep; 2023 Jan; 50(1):167-172. PubMed ID: 36319782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
    Derakhshani A; Asadzadeh Z; Baradaran B; Safarpour H; Rahmani S; Leone P; Abdoli Shadbad M; Hosseinkhani N; Ghasemigol M; Ayromlou H; Ahmadi H; Pouya S; Shojaee M; Tabrizi NJ; Miraki Feriz A; Safarzadeh E; Racanelli V
    Biomed Pharmacother; 2022 Apr; 148():112725. PubMed ID: 35183994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenicity of molecularly cloned bovine leukemia virus.
    Rovnak J; Boyd AL; Casey JW; Gonda MA; Jensen WA; Cockerell GL
    J Virol; 1993 Dec; 67(12):7096-105. PubMed ID: 8230433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line.
    Gutiérrez S; Ceriani C; Juliarena M; Ferrer JF
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):246-58. PubMed ID: 19497626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A field evaluation of the polymerase chain reaction procedure for the detection of bovine leukaemia virus proviral DNA in cattle.
    Eaves FW; Molloy JB; Dimmock CK; Eaves LE
    Vet Microbiol; 1994 Apr; 39(3-4):313-21. PubMed ID: 8042277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional study to describe bovine leukemia virus herd and within-herd ELISA prevalence and bovine leukemia virus proviral load of convenience-sampled Kansas beef cow-calf herds.
    Huser SM; Larson RL; Taxis TM; Almaraz JM; Reif KE; Weaver B; Amrine DE; Bartlett PC
    Am J Vet Res; 2022 Dec; 84(2):. PubMed ID: 36520647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV).
    Lawson JS; Salmons B; Glenn WK
    Front Oncol; 2018; 8():1. PubMed ID: 29404275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
    Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
    J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep.
    Usui T; Konnai S; Tajima S; Watarai S; Aida Y; Ohashi K; Onuma M
    J Vet Med Sci; 2003 Nov; 65(11):1201-5. PubMed ID: 14665749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced humoral immunity and atypical cell-mediated immunity in response to vaccination in cows naturally infected with bovine leukemia virus.
    Frie MC; Sporer KR; Wallace JC; Maes RK; Sordillo LM; Bartlett PC; Coussens PM
    Vet Immunol Immunopathol; 2016 Dec; 182():125-135. PubMed ID: 27863543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.